Edoardo Nicolò Aiello, Federica Solca, Silvia Torre, Beatrice Curti, Giulia De Luca, Ruggero Bonetti, Francesco Scheveger, Eleonora Colombo, Alessio Maranzano, Marco Olivero, Claudia Morelli, Alberto Doretti, Luca Maderna, Federico Verde, Roberta Ferrucci, Sergio Barbieri, Fabiana Ruggiero, Denise Mellace, Angelica Marfoli, Angelica De Sandi, Alberto Priori, Gabriella Pravettoni, Vincenzo Silani, Nicola Ticozzi, Andrea Ciammola, Barbara Poletti
{"title":"意大利语版蒙特利尔认知评估 (MoCA) 在非痴呆帕金森病患者中的可靠变化指数。","authors":"Edoardo Nicolò Aiello, Federica Solca, Silvia Torre, Beatrice Curti, Giulia De Luca, Ruggero Bonetti, Francesco Scheveger, Eleonora Colombo, Alessio Maranzano, Marco Olivero, Claudia Morelli, Alberto Doretti, Luca Maderna, Federico Verde, Roberta Ferrucci, Sergio Barbieri, Fabiana Ruggiero, Denise Mellace, Angelica Marfoli, Angelica De Sandi, Alberto Priori, Gabriella Pravettoni, Vincenzo Silani, Nicola Ticozzi, Andrea Ciammola, Barbara Poletti","doi":"10.1186/s12883-024-03920-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>. The present study aimed at deriving regression-based reliable change indices (RCIs) for the Montreal Cognitive Assessment (MoCA) in an Italian cohort of non-demented Parkinson's disease (PD) patients.</p><p><strong>Methods: </strong>N = 33 consecutive, non-demented PD patients were followed-up at a 5-to-8-month interval (M = 6.6; SD = 0.6) with the MoCA. Practice effects and test-retest reliability were assessed via dependent-sample t-tests and intra-class correlation (ICC) coefficients, respectively. RCIs were derived separately for raw and demographically adjusted MoCA scores according to a standardized regression-based approach by accounting for both baseline confounders (i.e., demographics, disease duration and Unified Parkinson's Disease Rating Scale scores) and retest interval.</p><p><strong>Results: </strong>No practice effects were found (t(32) = 0.29; p = .778), with acceptable test-retest reliability being detected (ICC = 0.67). MoCA scores at T0 proved to be the only significant predictor of T1 MoCA performances within both the model addressing raw scores and that addressing adjusted scores (ps < 0.001).</p><p><strong>Conclusions: </strong>The present study provides Italian practitioners and researchers with regression-based RCIs for the MoCA in non-demented PD patients, which can be reliably adopted for retest interval ≥ 5 and ≤ 8 months without encountering any practice effect.</p>","PeriodicalId":9170,"journal":{"name":"BMC Neurology","volume":"24 1","pages":"427"},"PeriodicalIF":2.2000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11533291/pdf/","citationCount":"0","resultStr":"{\"title\":\"Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patients.\",\"authors\":\"Edoardo Nicolò Aiello, Federica Solca, Silvia Torre, Beatrice Curti, Giulia De Luca, Ruggero Bonetti, Francesco Scheveger, Eleonora Colombo, Alessio Maranzano, Marco Olivero, Claudia Morelli, Alberto Doretti, Luca Maderna, Federico Verde, Roberta Ferrucci, Sergio Barbieri, Fabiana Ruggiero, Denise Mellace, Angelica Marfoli, Angelica De Sandi, Alberto Priori, Gabriella Pravettoni, Vincenzo Silani, Nicola Ticozzi, Andrea Ciammola, Barbara Poletti\",\"doi\":\"10.1186/s12883-024-03920-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>. The present study aimed at deriving regression-based reliable change indices (RCIs) for the Montreal Cognitive Assessment (MoCA) in an Italian cohort of non-demented Parkinson's disease (PD) patients.</p><p><strong>Methods: </strong>N = 33 consecutive, non-demented PD patients were followed-up at a 5-to-8-month interval (M = 6.6; SD = 0.6) with the MoCA. Practice effects and test-retest reliability were assessed via dependent-sample t-tests and intra-class correlation (ICC) coefficients, respectively. RCIs were derived separately for raw and demographically adjusted MoCA scores according to a standardized regression-based approach by accounting for both baseline confounders (i.e., demographics, disease duration and Unified Parkinson's Disease Rating Scale scores) and retest interval.</p><p><strong>Results: </strong>No practice effects were found (t(32) = 0.29; p = .778), with acceptable test-retest reliability being detected (ICC = 0.67). MoCA scores at T0 proved to be the only significant predictor of T1 MoCA performances within both the model addressing raw scores and that addressing adjusted scores (ps < 0.001).</p><p><strong>Conclusions: </strong>The present study provides Italian practitioners and researchers with regression-based RCIs for the MoCA in non-demented PD patients, which can be reliably adopted for retest interval ≥ 5 and ≤ 8 months without encountering any practice effect.</p>\",\"PeriodicalId\":9170,\"journal\":{\"name\":\"BMC Neurology\",\"volume\":\"24 1\",\"pages\":\"427\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-11-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11533291/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Neurology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12883-024-03920-9\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12883-024-03920-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patients.
Background: . The present study aimed at deriving regression-based reliable change indices (RCIs) for the Montreal Cognitive Assessment (MoCA) in an Italian cohort of non-demented Parkinson's disease (PD) patients.
Methods: N = 33 consecutive, non-demented PD patients were followed-up at a 5-to-8-month interval (M = 6.6; SD = 0.6) with the MoCA. Practice effects and test-retest reliability were assessed via dependent-sample t-tests and intra-class correlation (ICC) coefficients, respectively. RCIs were derived separately for raw and demographically adjusted MoCA scores according to a standardized regression-based approach by accounting for both baseline confounders (i.e., demographics, disease duration and Unified Parkinson's Disease Rating Scale scores) and retest interval.
Results: No practice effects were found (t(32) = 0.29; p = .778), with acceptable test-retest reliability being detected (ICC = 0.67). MoCA scores at T0 proved to be the only significant predictor of T1 MoCA performances within both the model addressing raw scores and that addressing adjusted scores (ps < 0.001).
Conclusions: The present study provides Italian practitioners and researchers with regression-based RCIs for the MoCA in non-demented PD patients, which can be reliably adopted for retest interval ≥ 5 and ≤ 8 months without encountering any practice effect.
期刊介绍：
BMC Neurology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of neurological disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
